<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01665248</url>
  </required_header>
  <id_info>
    <org_study_id>AMCCV2012-03</org_study_id>
    <nct_id>NCT01665248</nct_id>
  </id_info>
  <brief_title>Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina</brief_title>
  <official_title>Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHEOL WHAN LEE, MD, PhD.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CardioVascular Research Foundation, Korea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the correlations between active calcification and
      vulnerable plaque.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Standardized 18F-NaF uptake value within the culprit plaque</measure>
    <time_frame>At the time of diagnosis</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The relationship between 18F-NaF uptake value and calcium scores by Multidetector Computed Tomography</measure>
    <time_frame>at the time of diagnosis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relationship between 18F-NaF uptake value and plaque types by Multidetector Computed Tomography</measure>
    <time_frame>at the time of diagnosis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relationship between 18F-NaF uptake value and biomarkers</measure>
    <time_frame>at the time of diagnosis</time_frame>
    <description>hs-CRP, Troponin-I</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relationship between 18F-NaF uptake value and invasive imagings</measure>
    <time_frame>at the time of diagnosis</time_frame>
    <description>Intravascular ultrasound, Optical coherence tomography</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Coronary Artery Diseases</condition>
  <arm_group>
    <arm_group_label>stable angina pectoris or acute coronary syndrome</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>18-F Sodium Fluoride Uptake in Positron emission tomography</intervention_name>
    <arm_group_label>stable angina pectoris or acute coronary syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age more than 20

          -  Acute coronary syndrome or stable angina

        Exclusion Criteria:

          -  Contraindications to the use of heparin, aspirin, clopidogrel, stainless metal,
             contrast media

          -  Acute ST segment elevation myocardial infarction within 12hours, heart failure,
             cardiac shock

          -  Any serious medical comorbidity such that the subject's life expectancy is less than
             24 months

          -  Ejection fraction less than 30

          -  Serum creatinine level of 1.5mg/dl and over

          -  Vasculitis

          -  Unwillingness or inability to cooperate or to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cheol Whan Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2012</study_first_submitted>
  <study_first_submitted_qc>August 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2012</study_first_posted>
  <last_update_submitted>July 25, 2014</last_update_submitted>
  <last_update_submitted_qc>July 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>CardioVascular Research Foundation, Korea</investigator_affiliation>
    <investigator_full_name>CHEOL WHAN LEE, MD, PhD.</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>18-F Sodium Fluoride</keyword>
  <keyword>Acute coronary syndrome</keyword>
  <keyword>Stable Angina</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Sodium Fluoride</mesh_term>
    <mesh_term>Listerine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

